Stocktoria
electroCore, Inc. ECOR
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2018-06-22
electroCore, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 86.8% | 85.0% | 82.5% | 81.2% | 74.6% |
| Operating margin | -41.1% | -48.3% | -120.2% | -266.2% | -367.7% |
| Net margin | -43.6% | -47.2% | -117.5% | -257.9% | -315.9% |
| FCF margin | 25.4% | — | 90.4% | — | — |
| Return on assets | -74.8% | -58.1% | -117.0% | -89.5% | -40.2% |
| Return on equity | 817.2% | -157.6% | -253.1% | -129.7% | -47.0% |
| Debt / equity | -4.54× | — | — | — | — |
| Current ratio | 1.38 | 1.78 | 1.76 | 3.01 | 6.84 |
| Revenue growth | 27.2% | 57.1% | 86.6% | 57.6% | 55.9% |
Source: SEC EDGAR filings · CIK 0001560258 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.